Please check your internet connection and try again.
# Sompraz HP
## Overview
Sompraz HP is a prescription "Helicobacter Pylori kit" (a combination pack). It typically contains a fixed-dose combination of **Esomeprazole** (a proton pump inhibitor), **Amoxicillin** (a penicillin antibiotic), and **Clarithromycin** (a macrolide antibiotic).
## Primary Indications
Treatment of *Helicobacter pylori* infection to reduce the risk of duodenal ulcer recurrence.
## Adult Dosing
Standard therapy consists of the following, usually taken twice daily (morning and evening) for 7 to 14 days, depending on local prescribing guidelines:
* **Esomeprazole:** 40 mg twice daily.
* **Amoxicillin:** 1000 mg twice daily.
* **Clarithromycin:** 500 mg twice daily.
* *Note:* Always follow the specific blister pack instructions provided in the kit.
## Pediatric Dosing
* **Not indicated.** Safety and efficacy have not been established in the pediatric population.
## Dose Adjustments
* **Renal Impairment:** Amoxicillin dose usually requires reduction if CrCl <30 mL/min. Clarithromycin may require adjustment in severe renal impairment (CrCl <30 mL/min).
* **Hepatic Impairment:** Caution with Clarithromycin; may require dose reduction or avoidance in severe liver disease. Esomeprazole does not typically require adjustment in mild-to-moderate impairment, but use caution in severe hepatic disease (max 20 mg/day).
## Contraindications
* Hypersensitivity to any component (Esomeprazole, Amoxicillin, Clarithromycin).
* Patients with a history of cholestatic jaundice or hepatic dysfunction associated with clarithromycin use.
* **Concurrent use** with drugs known to cause QT prolongation (e.g., pimozide, astemizole, terfenadine, cisapride) due to clarithromycin.
* History of penicillin allergy (severe).
## Adverse Effects
* **Common:** Diarrhea, dysgeusia (metallic taste), nausea, abdominal pain, headache, and dizziness.
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hypersensitivity reactions (anaphylaxis/Stevens-Johnson syndrome), QTc prolongation, and hepatotoxicity.
## Key Drug Interactions
* **CYP3A4 Substrates:** Clarithromycin is a potent CYP3A4 inhibitor; increased levels of drugs like statins (e.g., simvastatin/lovastatin – increased risk of rhabdomyolysis), benzodiazepines, and warfarin may occur.
* **pH-Dependent Drugs:** Esomeprazole increases gastric pH, reducing absorption of atazanavir, nelfinavir, and ketoconazole.
* **Methotrexate:** PPIs may increase methotrexate levels.
## Monitoring
* Monitor for signs of *C. difficile* diarrhea (persistent watery/bloody stools).
* Monitor for signs of hypersensitivity.
* Baseline and periodic LFTS if on long-term therapy or higher risks.
* Assess for resolution of symptoms; confirm *H. pylori* eradication 4 weeks after completion of therapy via urea breath test or stool antigen testing.
## Clinical Pearls
* **Adherence:** High success rates depend on strict patient adherence to the full 7–14 day course despite gastrointestinal side effects.
* **Resistance:** Increasing resistance of *H. pylori* to clarithromycin has reduced efficacy in certain geographic regions. Consult local antibiograms.
* **Administration:** Esomeprazole dosing is usually optimal at least 30–60 minutes before meals.
***
**Educational Disclaimer:** This information is for educational purposes only. Always consult the latest package insert, product monograph, or official local prescribing guidelines before prescribing or dispensing, as formulations by brand name can vary by region.
